Japan's Palliative care market is projected to grow from $813.03 Mn in 2022 to $1561.52 Mn by 2030, registering a CAGR of 8.5% during the forecast period of 2022-30. The main factors driving the growth would be the growing homecare industry, technological advancements, the ageing population, and government support. The market is segmented by service type and by the end user. Some of the major players include Aichi International Hospital, Anjo Koesei Hospital, Nikko Memorial Hospital, Fukuyama City Hospital, and Home Instead.
Japan's Palliative care market is projected to grow from $813.03 Mn in 2022 to $1561.52 Mn by 2030, registering a CAGR of 8.5% during the forecast period of 2022-30. Healthcare spending in Japan increased from $4,256 to $4,360 per capita while falling from 10.75% of GDP in 2018 to 10.74% in 2019. Japan spends more on healthcare than the worldwide average for developed countries.
Palliative care is a method that improves the quality of life for people with life-threatening illnesses and their families. Through early detection, accurate assessment, and treatment of pain and other disorders, including those that are physical, mental, or spiritual, palliative care services prevent and alleviate suffering. Additionally, palliative care supports patients and their carers by using a collaborative approach. This entails attending to practical needs and offering a support structure to help people live as actively as possible until death. For a wide range of diseases, including cancer, chronic respiratory illnesses, diabetes, kidney failure, chronic liver disease, and others, palliative care is crucial.
Market Growth Drivers
The Japanese palliative care market is expected to be driven by factors such as the growing homecare industry, technological advancements, and government support. Moreover, with a population that is rapidly aging, Japan has one of the greatest elderly populations in the world. Palliative care services are in greater demand as a result of this.
Market Restraints
The high cost of palliative care services and the fragmented delivery methods are issues that are preventing the palliative care market in Japan from expanding. Palliative care services are frequently dispersed, which can hinder market expansion, lead to poor care coordination, and result in less-than-ideal outcomes for patients.
Key Players
The Japanese healthcare system offers access to high-quality end-of-life care treatments and takes a comprehensive approach to palliative care. Recognizing the significance of palliative care, the Japanese government has put in place a number of laws and policies to guarantee that patients get the best care available. Guidelines for palliative care services have been set by the Ministry of Health, Labor and Welfare (MHLW), which is the main organization in charge of creating and carrying out healthcare policy in Japan. The recommendations offer a framework for offering patients and their families comprehensive and compassionate palliative care. In order to preserve the long-term viability of these programs, the government also gives financial assistance to hospitals and clinics that offer palliative care services.
Palliative care services are subject to regulation by the MHLW, and healthcare providers must abide by the set rules and regulations in order to offer patients high-quality care. The government also conducts routine inspections of hospitals and clinics to make sure they are delivering palliative care services in compliance with the specified criteria.
In Japan, the national health insurance program pays for palliative care services. The Ministry of Health, Labor and Welfare (MHLW) establishes the reimbursement guidelines for palliative care services in Japan in coordination with the Japan Medical Association (JMA) and the Japan Hospice and Palliative Care Association (JHPCA). These insurance plans cover the cost of palliative care patients' medical treatments, such as prescription medications, as well as support services, such as nursing care and counseling. There are various financial assistance programs in addition to the national health insurance program that can assist patients and their families with the expense of palliative care services. The Long-Term Care Insurance (LTCI) program, for instance, offers financial assistance to patients who require long-term care, including palliative care treatments. The system also covers a variety of services, including nursing care, rehabilitation, and support for carers.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Service Type (Revenue, USD Billion):
Based on service type, the Japan palliative care market is divided into the following:
By End User (Revenue, USD Billion):
Based on end-user type, the Japan palliative care market is divided into the following:
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.